Paradromics, Inc.

Brain-Computer Interface (BCI) for Neurological Conditions | Paradromics

Austin, United States · Founded 2016 · $57.0M raised

Headquarters
Austin, Texas
Employees
11–50
Founded
2016
Total Funding
$57.0M
Last Round
$33.0M Series AFeb 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

R&D company with 2 SBIR/STTR awards from Department of Health and Human Services.

Summary

Paradromics, Inc. is a Biotech company based in Austin, United States, founded in 2016. It has raised $57.0M in total across 4 rounds, most recently a $33.0M Series A round in Feb 2025. Investors include Prime Movers Lab.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2025
$33.0M

Sign up to see all 4 events

Funding: Grant through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Paradromics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/paradromics-inc"><img src="https://indexed.vc/api/badge/company/paradromics-inc" alt="Paradromics, Inc. on Indexed.vc" width="260" height="76" /></a>